Could fractional mRNA COVID-19 vaccines reduce myocarditis in adolescents?
Authors:
- 14 September 2021
- journal article
- letter
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 44, 102164
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Myocarditis after Covid-19 mRNA VaccinationNew England Journal of Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Final ReportNew England Journal of Medicine, 2019